Nearly 7,400 transvaginal mesh lawsuits are now pending in the consolidated litigation involving implants from Johnson & Johnson’s Ethicon unit.
According to court documents dated December 29th, 2014, a total of 7,396 claims are now pending in Bergen County Superior Court, where a state proceeding involving Ethicon’s line of Gynecare implants is underway. Claims filed in the New Jersey litigation similarly accuse the manufacturer of various transvaginal mesh devices of failing to adequately warn about mesh erosion, chronic pain and other complications that may stem from their use. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10)
Transvaginal Mesh Lawsuits
According to court documents, all the transvaginal mesh lawsuits now pending in New Jersey’s Ethicon mesh litigation follow a 2008 alert from the U.S. Food and Drug Administration (FDA) that use of the devices may result in various complications, but that the potential for which was “rare.” In July 2011, the federal agency revised its stance after receiving 3,000 adverse event reports over a three-year period from women who received mesh implants. The risk for vaginal mesh problems was re-categorized at this time as “not rare.” Following these public health alerts, the FDA proposed new regulations in April 2014 that would classify transvaginal mesh devices as high-risk, which would require manufacturers to submit them for rigorous safety testing prior to receiving U.S. market clearance.